1. The Laws of New York
  2. Consolidated Laws
  3. Public Health
  4. Article 33: Controlled Substances Title I General Provisions
  5. Title 1: General Provisions


Section 3306 Schedules of controlled substances

Public Health (PBH)

There are hereby established five schedules of controlled substances, to be known as schedules I, II, III, IV and V respectively. Such schedules shall consist of the following substances by whatever name or chemical designation known:

  Schedule I. (a) Schedule I shall consist of the drugs and other substances, by whatever official name, common or usual name, chemical name, or brand name designated, listed in this section.

  (b) Opiates. Unless specifically excepted or unless listed in another schedule, any of the following opiates, including their isomers, esters, ethers, salts, and salts of isomers, esters, and ethers, whenever the existence of such isomers, esters, ethers and salts is possible within the specific chemical designation (for purposes of 3-methylfentanyl only, the term isomer includes the optical and geometric isomers):

  (1) Acetyl-alpha-methylfentanyl (N-{1-(-methyl-2-phenethyl) -4-piperidinyl} -N-phenylacetamide.

  (2) Acetylmethadol.

  (3) Allylprodine.

  (4) Alphacetylmethadol (except levo- alphacetylmethadol also known as levo-alpha-acetylmethadol, levomethadylacetate or LAAM).

  (5) Alphameprodine.

  (6) Alphamethadol.

  (7) Alpha-methylfentanyl (N-{1-(alpha-methyl-beta-phenyl) ethyl-4-piperidyl} propionanilide; 1-(1-methyl-2-phenylethyl) -4-(N-propanilido) piperidine).

  (8) Alpha-methylthiofentanyl (N-{1-methyl-2)2-thienyl) ethyl-4-piperidinyl} -N-phenylpropanamide).

  (9) Beta-hydroxyfentanyl (N-{1-2 (2-hydroxy-2-phenethyl)- 4-piperidinyl} -N-phenylpropanamide).

  (10) Beta-hydroxy-3-methylfentanyl (other name: N-{1- (2-hydroxy-2-phenethyl) -3-methyl -4-piperidinyl} -N-phenylpropanamide.

  (11) Benzethidine.

  (12) Betacetylmethadol.

  (13) Betameprodine.

  (14) Betamethadol.

  (15) Betaprodine.

  (16) Clonitazene.

  (17) Dextromoramide.

  (18) Diampromide.

  (19) Diethylthiambutene.

  (20) Difenoxin.

  (21) Dimenoxadol.

  (22) Dimepheptanol.

  (23) Dimethylthiambutene.

  (24) Dioxaphetyl butyrate.

  (25) Dipipanone.

  (26) Ethylmethylthiambutene.

  (27) Etonitazene.

  (28) Etoxeridine.

  (29) Furethidine.

  (30) Hydroxypethidine.

  (31) Ketobemidone.

  (32) Levomoramide.

  (33) Levophenacylmorphan.

  (34) 3-Methylfentanyl (N-{3-methy1-1- (2- phenylethyl -4-piperidyl} -N-phenylpropanamide).

  (35) 3-Methylthiofentanyl (N-{3-methyl-1- (2-thienyl)ethyl -4-piperidinyl} -N-phenylpropanamide).

  (36) Morpheridine.

  (37) MPPP (1-methyl -4-phenyl -4-propionoxypiperidine).

  (38) Noracymethadol.

  (39) Norlevorphanol.

  (40) Normethadone.

  (41) Norpipanone.

  (42) Para-fluorofentanyl (N- (4-fluorophenyl) -N-{1- (2-phenethyl) -4-piperidinyl} -propanamide.

  (43) PEPAP (1- (-2-phenethyl) -4-phenyl -4-acetoxypiperidine.

  (44) Phenadoxone.

  (45) Phenampromide.

  (46) Phenomorphan.

  (47) Phenoperidine.

  (48) Piritramide.

  (49) Proheptazine.

  (50) Properidine.

  (51) Propiram.

  (52) Racemoramide.

  (53) Thiofentanyl (N-phenyl-N-{1- (2-thienyl) ethyl -4- piperidinyl} -propanamide.

  (54) Tilidine.

  (55) Trimeperidine.

  (56) 3,4-dichloro-N-{(1-dimethylamino) cyclohexylmethyl}benzamide. Some trade or other names: AH-7921.

  (57) N-(1-phenethylpiperidin-4-yl)-N-phenylacetamide (Acetyl Fentanyl).

  (c) Opium derivatives. Unless specifically excepted or unless listed in another schedule, any of the following opium derivatives, its salts, isomers, and salts of isomers whenever the existence of such salts, isomers, and salts of isomers is possible within the specific chemical designation:

  (1) Acetorphine.

  (2) Acetyldihydrocodeine.

  (3) Benzylmorphine.

  (4) Codeine methylbromide.

  (5) Codeine-N-oxide.

  (6) Cyprenorphine.

  (7) Desomorphine.

  (8) Dihydromorphine.

  (9) Drotebanol.

  (10) Etorphine (except hydrochloride salt).

  (11) Heroin.

  (12) Hydromorphinol.

  (13) Methyldesorphine.

  (14) Methyldihydromorphine.

  (15) Morphine methylbromide.

  (16) Morphine methylsulfonate.

  (17) Morphine-N-oxide.

  (18) Myrophine.

  (19) Nicocodeine.

  (20) Nicomorphine.

  (21) Normorphine.

  (22) Pholcodine.

  (23) Thebacon.

  (d) Hallucinogenic substances. Unless specifically excepted or unless listed in another schedule, any material, compound, mixture, or preparation, which contains any quantity of the following hallucinogenic substances, or which contains any of its salts, isomers, and salts of isomers whenever the existence of such salts, isomers, and salts of isomers is possible within the specific chemical designation (for purposes of this paragraph only, the term "isomer" includes the optical, position and geometric isomers): (EXPLANATION--Within the following chemical designations, character

  symbol substitutions were made from the original text: "@" = Greek

  alpha, "&" = Greek beta, "'" = prime mark and "/\" = triangle.)

  (1) 4-bromo-2, 5-dimethoxy-amphetamine Some trade or other names: 4-bromo-2, 5-dimethoxy-@-methylphenethylamine; 4-bromo-2, 5-DMA.

  (2) 2, 5-dimethoxyamphetamine Some trade or other names: 2, 5-dimethoxy-@-methylphenethylamine; 2, 5-DMA.

  (3) 4-methoxyamphetamine Some trade or other names: 4-methoxy-@-methylphenethylamine; paramethoxyamphetamine, PMA.

  (4) 5-methoxy-3, 4-methylenedioxy - amphetamine.

  (5) 4-methyl-2, 5-dimethoxy-amphetamine Some trade and other names: 4-methyl-2, 5-dimethoxy-@-methylphenethylamine; "DOM"; and "STP".

  (6) 3, 4-methylenedioxy amphetamine.

  (7) 3, 4, 5-trimethoxy amphetamine.

  (8) Bufotenine Some trade and other names: 3-(&-dimethylaminoethyl)-5 hydroxindole; 3-(2-dimethylaminoethyl)- 5-indolol; N, N-dimethylserotonin; -5-hydroxy-N, N-dimethyltryptamine; mappine.

  (9) Diethyltryptamine Some trade and other names: N, N-diethyltryptamine; DET.

  (10) Dimethyltryptamine Some trade or other names: DMT.

  (11) Ibogane Some trade and other names: 7-ethyl-6, 6&, 7, 8, 9, 10, 12, 13-octahydro-2-methoxy-6, 9-methano-5h-pyrido {1',2':1,2} azepino {5,4-b} indole: tabernanthe iboga.

  (12) Lysergic acid diethylamide.

  (13) Marihuana.

  (14) Mescaline.

  (15) Parahexyl. Some trade or other names: 3-Hexyl-1-hydroxy- 7,8,9,10-tetra hydro-6,6,9-trimethyl-6H-dibenfo{b,d} pyran.

  (16) Peyote. Meaning all parts of the plant presently classified botanically as Lophophora williamsii Lemaire, whether growing or not, the seeds thereof, any extract from any part of such plant, and every compound, manufacture, salts, derivative, mixture, or preparation of such plant, its seeds or extracts.

  (17) N-ethyl-3-piperidyl benzilate.

  (18) N-methyl-3-piperidyl benzilate.

  (19) Psilocybin.

  (20) Psilocyn.

  (21) Tetrahydrocannabinols. Synthetic equivalents of the substances contained in the plant, or in the resinous extractives of cannabis, sp. and/or synthetic substances, derivatives, and their isomers with similar chemical structure and pharmacological activity such as the following:

  /\1 cis or trans tetrahydrocannabinol, and their optical isomers

  /\6 cis or trans tetrahydrocannabinol, and their optical isomers

  /\3, 4 cis or trans tetrahydrocannabinol, and its optical isomers (since nomenclature of these substances is not internationally standardized, compounds of these structures, regardless of numerical designation of atomic positions covered).

  (22) Ethylamine analog of phencyclidine. Some trade or other names: N-ethyl-1-phenylcyclohexylamine, (1-phenylcyclohexyl) ethylamine, N-(1-phenylcyclohexyl) ethylamine cyclohexamine, PCE.

  (23) Pyrrolidine analog of phencyclidine. Some trade or other names 1-(1-phenylcyclohexyl)-pyrrolidine; PCPy, PHP.

  (24) Thiophene analog of phencyclidine. Some trade or other names: 1-{1-(2-thienyl)-cyclohexyl}-piperidine, 2-thienylanalog of phencyclidine, TPCP, TCP.

  (25) 3,4-methylenedioxymethamphetamine (MDMA).

  (26) 3,4-methylendioxy-N-ethylamphetamine (also known as N-ethyl-alpha-methyl-3,4 (methylenedioxy) phenethylamine, N-ethyl MDA, MDE, MDEA.

  (27) N-hydroxy-3,4-methylenedioxyamphetamine (also known as N-hydroxy-alpha-methyl-3,4 (methylenedioxy) phenethylamine, and N-hydroxy MDA.

  (28) 1-{1- (2-thienyl) cyclohexyl} pyrrolidine. Some other names: TCPY.

  (29) Alpha-ethyltryptamine. Some trade or other names: etryptamine; Monase; Alpha-ethyl-1H-indole-3-ethanamine; 3- (2-aminobutyl) indole; Alpha-ET or AET.

  (30) 2,5-dimethoxy-4-ethylamphetamine. Some trade or other names: DOET.

  (31) 4-Bromo-2,5-dimethoxyphenethylamine. Some trade or other names: 2-(4-bromo-2,5-dimethoxyphenyl)-1-aminoethane; alpha-desmethyl DOB; 2C-B, Nexus.

  (32) 2,5-dimethoxy-4-(n)-propylthiophenethylamine (2C-T-7), its optical isomers, salts and salts of isomers.

  (33) 2-(4-iodo-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl)ethanamine, also known as 25I-NBOMe; 2C-I-NBOMe; 25I; or Cimbi-5.

  (34) 2-(4-chloro-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl)ethanamine, also known as 25 CNBOMe; 2C-C-NBOMe; 25C; or Cimbi-82.

  (35) 2-(4-bromo-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl)ethanamine, also known as, 25 BNBOMe; 2C-B-NBOMe; Cimbi-36.

  (36) 5-methoxy-N,N-dimethyltryptamine.

  (37) Alpha-methyltryptamine. Some trade or other names: AMT.

  (38) 5-methoxy-N,N-diisopropyltryptamine. Some trade or other names: 5-MeO-DIPT.

  (e) Depressants. Unless specifically excepted or unless listed in another schedule, any material, compound, mixture, or preparation which contains any quantity of the following substances having a depressant effect on the central nervous system, including its salts, isomers, and salts of isomers whenever the existence of such salts, isomers, and salts of isomers is possible within the specific chemical designation:

  (1) Mecloqualone.

  (2) Methaqualone.

  (3) Phencyclidine.

  (4) Gamma hydroxybutyric acid, and salt, hydroxybutyric compound, derivative or preparation of gamma hydroxybutyric acid, including any isomers, esters and ethers and salts of isomers, esters and ethers of gamma hydroxybutyric acid, except gamma-butyrolactone, whenever the existence of such isomers, esters and ethers and salts is possible within the specific chemical.

  (5) Gamma-butyrolactone, including butyrolactone; butyrolactone gamma; 4-butyrolactone; 2(3H)-furanone dihydro; dihydro-2(3H)-furanone; tetrahydro-2-furanone; 1,2-butanolide; 1,4-butanolide; 4-butanolide; gamma-hydroxybutyric acid lactone; 3-hydroxybutyric acid lactone and 4-hydroxybutanoic acid lactone with Chemical Abstract Service number (96-48-0) when any such substance is intended for human consumption.

  (6) 1,4 butanediol, including butanediol; butane-1,4-diol; 1,4-butylene glyco; butylene glycol; 1,4-dihydroxybutane; 1,4-tetramethylene glycol; tetramethylene glycol; tetramethylene Abstract Service number (110-63-4) when any such substance is intended for human consumption.

  (f) Stimulants. Unless specifically excepted or unless listed in another schedule, any material, compound, mixture, or preparation which contains any quantity of the following substances having a stimulant effect on the central nervous system, including its salts, isomers, and salts of isomers:

  (1) Fenethylline.

  (2) N-ethylamphetamine.

  (3) (+ -)cis-4-methylaminorex ((+ -)cis-4,5-dihydro-4-methyl -5-phenyl -2-oxazolamine).

  (4) N,N-dimethylamphetamine (also known as N,N-alpha- trimethyl-benzeneethanamine; N,N-alpha- trimethylphenethylamine).

  (5) Methcathinone (some other names: 2-(methylamino) - propiophenone; alpha-(methylamino) propiophenone; 2-(methylamino) -1-phenylpropan- 1-one; alpha-N- methylaminopropiophenone; monomethylpropion; ephedrone, N-methylcathinone, methylcathinone; AL-464; AL-422; AL-463 and UR1432), its salts, optical isomers and salts of optical isomers.

  (6) Aminorex. Some other names: aminoxaphen; 2-amino-5-phenyl -2-oxazoline; or 4,5-dihydro-5-phenyl-2-oxazolamine.

  (7) Cathinone. Some trade or other names: 2-amino-1-phenyl-1-propanone, alpha-aminopropiophenone, 2-aminopropiophenone, and norephedrone.

  (8) N-benzylpiperazine (some other names: BZP; 1-benzylpiperazine), its optical isomers, salts and salts of isomers.

  (9) 4-methyl-N-methylcathinone or 4-Methylmethcathinone, also known as Mephedrone.

  (10) 3,4-methylenedioxypyrovalerone or Methylenedioxypyrovalerone, also known as MDPV.

  (11) 3,4-methylenedioxy-N-methylcathinone (some other names: methylone).

  (12) 4-Methoxymethcathinone.

  (13) 3-Fluoromethcathinone.

  (14) 4-Fluoromethcathinone.

  (15) Ethylpropion (Ethcathinone).

  (16) 2-(2,5-Dimethoxy-4-ethylphenyl)ethanamine (2C-E).

  (17) 2-(2,5-Dimethoxy-4-methylphenyl)ethanamine (2C-D).

  (18) 2-(4-Chloro-2,5-dimethoxyphenyl)ethanamine (2C-C).

  (19) 2-(4-Iodo-2,5-dimethoxyphenyl)ethanamine (2C-I).

  (20) 2-{4-(Ethylthio)-2,5-dimethoxyphenyl}ethanamine (2C-T-2).

  (21) 2-{4-(Isopropylthio)-2,5-dimethoxyphenyl}ethanamine (2C-T-4).

  (22) 2-(2,5-Dimethoxyphenyl)ethanamine (2C-H).

  (23) 2-(2,5-Dimethoxy-4-nitro-phenyl)ethanamine (2C-N).

  (24) 2-(2,5-Dimethoxy-4-(n)-propylphenyl)ethanamine (2C-P).

  (g) Synthetic cannabinoids. Unless specifically excepted or unless listed in another schedule, any material, compound, mixture, or preparation, which contains any quantity of the following synthetic cannabinoid substances, or which contains any of its salts, isomers, and salts of isomers whenever the existence of such salts, isomers, and salts of isomers is possible within the specific chemical designation (for purposes of this paragraph only, the term "isomer" includes the optical, position and geometric isomers):

  (1) (1-pentyl-1H-indol-3-yl)(2,2,3,3-tetramethylcyclopropyl) methanone. Some trade or other names: UR-144.

  (2) {1-(5-fluro-pentyl)-1H-indol-3-yl}(2,2,3,3-tetramethylcyclopropyl) methanone. Some trade names or other names: 5-fluoro-UR-144, XLR11.

  (3) N-(1-adamantyl)-1-pentyl-1H-indazole-3-carboxamide. Some trade or other names: APINACA, AKB48.

  (4) quinolin-8-yl 1-pentyl-1H-indole-3-carboxylate. Some trade or other names: PB-22; QUPIC.

  (5) quinolin-8-yl 1-(5-fluoropentyl)-1H-indole-3-carboxylate. Some trade or other names: 5-fluoro-PB-22; 5F-PB-22.

  (6) N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(4-fluorobenzyl)-1H-indazo- le-3-carboxamide. Some trade or other names: AB-FUBINACA.

  (7) N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-pentyl-1H-indazole-3- carboxamide. Some trade or other names: ADB-PINACA.

  (8) N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(cyclohexylmethyl)-1H- indazole-3-carboxamide. Some trade or other names: AB-CHMINACA.

  (9) N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-pentyl-1H-indazole-3- carboxamide. Some trade or other names: AB-PINACA.

  (10) {1-(5-fluoropentyl)-1H-indazol-3-yl}(naphthalen-1-y1)methanone. Some trade or other names: THJ-2201.

  (h) (1) Cannabimimetic agents. Unless specifically exempted or unless listed in another schedule, any material, compound, mixture, or preparation that is not approved by the federal food and drug administration (FDA) which contains any quantity of cannabimimetic agents, or which contains their salts, isomers, and salts of isomers whenever the existence of such salts, isomers, and salts of isomers is possible within the specific chemical designation.

  (2) As used in this subdivision, the term "cannabimimetic agents" means any substance that is a cannabinoid receptor type 1 (CB1 receptor) agonist as demonstrated by binding studies and functional assays within any of the following structural classes:

  (i) 2-(3-hydroxycyclohexyl)phenol with substitution at the 5-position of the phenolic ring by alkyl or alkenyl, whether or not substituted on the cyclohexyl ring to any extent.

  (ii) 3-(1-naphthoyl)indole or 3-(1-naphthylmethane)indole by substitution at the nitrogen atom of the indole ring, whether or not further substituted on the indole ring to any extent, whether or not substituted on the naphthoyl or naphthyl ring to any extent.

  (iii) 3-(1-naphthoyl)pyrrole by substitution at the nitrogen atom of the pyrrole ring, whether or not further substituted in the pyrrole ring to any extent, whether or not substituted on the naphthoyl ring to any extent.

  (iv) 1-(1-naphthylmethylene)indene by substitution of the 3-position of the indene ring, whether or not further substituted in the indene ring to any extent, whether or not substituted on the naphthyl ring to any extent.

  (v) 3-phenylacetylindole or 3-benzoylindole by substitution at the nitrogen atom of the indole ring, whether or not further substituted in the indole ring to any extent, whether or not substituted on the phenyl ring to any extent.

  (3) Such term includes:

  (i) 5-(1,1-dimethylheptyl)-2-{(1R,3S)-3-hydroxycyclohexyl}-phenol (CP-47,497);

  (ii) 5-(1,1-dimethyloctyl)-2-{(1R,3S)-3-hydroxycyclohexyl}-phenol (cannabicyclohexanol or CP-47,497 C8-homolog);

  (iii) 1-pentyl-3-(1-naphthoyl)indole (JWH-018 and AM678);

  (iv) 1-butyl-3-(1-naphthoyl)indole (JWH-073);

  (v) 1-hexyl-3-(1-naphthoyl)indole (JWH-019);

  (vi) 1-{2-(4-morpholinyl)ethyl}-3-(1-naphthoyl)indole (JWH-200);

  (vii) 1-pentyl-3-(2-methoxyphenylacetyl)indole (JWH-250);

  (viii) 1-pentyl-3-{1-(4-methoxynaphthoyl)}indole (JWH-081);

  (ix) 1-pentyl-3-(4-methyl-1-naphthoyl)indole (JWH-122);

  (x) 1-pentyl-3-(4-chloro-1-naphthoyl)indole (JWH-398);

  (xi) 1-(5-fluoropentyl)-3-(1-naphthoyl)indole (AM2201);

  (xii) 1-(5-fluoropentyl)-3-(2-iodobenzoyl)indole (AM694);

  (xiii) 1-pentyl-3-{(4-methoxy)-benzoyl}indole (SR-19 and RCS-4);

  (xiv) 1-cyclohexylethyl-3-(2-methoxyphenylacetyl)indole (SR-18 and RCS-8); and

  (xv) 1-pentyl-3-(2-chlorophenylacetyl)indole (JWH-203).

  Schedule II. (a) Schedule II shall consist of the drugs and other substances, by whatever official name, common or usual name, chemical name, or brand name designated, listed in this section.

  (b) Substances, vegetable origin or chemical synthesis. Unless specifically excepted or unless listed in another schedule, any of the following substances whether produced directly or indirectly by extraction from substances of vegetable origin, or independently by means of chemical synthesis, or by a combination of extraction and chemical synthesis:

  (1) Opium and opiate, and any salt, compound, derivative, or preparation of opium or opiate, excluding apomorphine, dextrorphan, nalbuphine, nalmefene, naloxone, and naltrexone, and their respective salts, but including the following:

  1. Raw opium.

  2. Opium extracts.

  3. Opium fluid.

  4. Powdered opium.

  5. Granulated opium.

  6. Tincture of opium.

  7. Codeine.

  8. Ethylmorphine.

  9. Etorphine hydrochloride.

  10. Hydrocodone (also known as dihydrocodeinone).

  11. Hydromorphone.

  12. Metopon.

  13. Morphine.

  14. Oxycodone.

  15. Oxymorphone.

  16. Thebaine.

  17. Dihydroetorphine.

  18. Oripavine.

  (2) Any salt, compound, derivative, or preparation thereof which is chemically equivalent or identical with any of the substances referred to in this section, except that these substances shall not include the isoquinoline alkaloids of opium.

  (3) Opium poppy and poppy straw.

  (4) Coca leaves and any salt, compound, derivative, or preparation of coca leaves, and any salt, compound, derivative, or preparation thereof which is chemically equivalent or identical with any of these substances including cocaine and ecgonine, their salts, isomers, and salts of isomers, except that the substances shall not include: (A) decocainized coca leaves or extraction of coca leaves, which extractions do not contain cocaine or ecgonine; or (B) {123I} ioflupane.

  (5) Concentrate of poppy straw (the crude extract of poppy straw in either liquid, solid or powder form which contains the phenanthrene alkaloids of the opium poppy).

  (b-1) Unless specifically excepted or unless listed in another schedule, any material, compound, mixture, or preparation containing any of the following, or their salts calculated as the free anhydrous base or alkaloid, in limited quantities as set forth below:

  (1) Not more than three hundred milligrams of dihydrocodeinone (hydrocodone) per one hundred milliliters or not more than fifteen milligrams per dosage unit, with a fourfold or greater quantity of an isoquinoline alkaloid of opium.

  (2) Not more than three hundred milligrams of dihydrocodeinone (hydrocodone) per one hundred milliliters or not more than fifteen milligrams per dosage unit, with one or more active nonnarcotic ingredients in recognized therapeutic amounts.

  (c) Opiates. Unless specifically excepted or unless in another schedule any of the following opiates, including its isomers, esters, ethers, salts and salts of isomers, esters and ethers whenever the existence of such isomers, esters, ethers, and salts is possible within the specific chemical designation, dextrorphan and levopropoxyphene excepted:

  (1) Alfentanil.

  (2) Alphaprodine.

  (3) Anileridine.

  (4) Bezitramide.

  (5) Bulk dextropropoxyphene (non-dosage forms).

  (6) Carfentanil.

  (7) Dihydrocodeine.

  (8) Diphenoxylate.

  (9) Fentanyl.

  (10) Isomethadone.

  (11) Levo-alphacetylmethadol (also known as levo-alpha-acetylmethadol, levomethadylacetate or LAAM).

  (12) Levomethorphan.

  (13) Levorphanol.

  (14) Metazocine.

  (15) Methadone.

  (16) Methadone-intermediate, 4-cyano-2-dimethylamino-4, 4-diphenyl butane.

  (17) Moramide-intermediate, 2-methyl-3-morpholino-1, 1--diphenylpropane--carboxylic acid.

  (18) Pethidine (meperidine).

  (19) Pethidine-intermediate-A, 4-cyano-1-methyl-4-phenylpiperidine.

  (20) Pethidine-intermediate-B, ethyl-4-phenylpiperidine-4-carboxylate.

  (21) Pethidine-intermediate-C, 1--methyl--4-- phenylpiperidine--4-- carboxylic acid.

  (22) Phenazocine.

  (23) Piminodine.

  (24) Racemethorphan.

  (25) Racemorphan.

  (26) Sufentanil.

  (27) Remifentanil.

  (28) Tapentadol.

  (d) Stimulants. Unless specifically excepted or unless listed in another schedule, any material, compound, mixture, or preparation which contains any quantity of the following substances having a stimulant effect on the central nervous system, including its salts, isomers, and salts of isomers:

  (1) Amphetamine.

  (2) Methamphetamine.

  (3) Phenmetrazine.

  (4) Methylphenidate.

  (5) Lisdexamfetamine.

  (e) Depressants. Unless specifically excepted or unless listed in another schedule, any material, compound, mixture, or preparation which contains any quantity of the following substances having a depressant effect on the central nervous system, including its salts, isomers, and salts of isomers whenever the existence of such salts, isomers, and salts of isomers is possible within the specific chemical designation:

  (1) Amobarbital.

  (2) Glutethimide.

  (3) Pentobarbital.

  (4) Secobarbital.

  (f) Hallucinogenic substances.

  Nabilone: Another name for nabilone: (+,-)-trans -3-(1,1-dimethylheptyl)-6, 6a, 7, 8, 10, 10a-hexahydro-1-hydroxy-6, 6-dimethyl-9H-dibenzo{b,d}pyran-9-one.

  (g) Immediate precursors. Unless specifically excepted or unless listed in another schedule, any material, compound, mixture or preparation which contains any quantity of the following substances:

  (1) Immediate precursor to amphetamine and methamphetamine:

  (i) Phenylacetone Some trade or other names: pheny1-2-propanone; P2P; benzyl methyl ketone; methyl benzyl ketone;

  (2) Immediate precursors to phencyclidine (PCP):

  (i) 1-phenylcyclohexylamine;

  (ii) 1-piperidinocyclohexanecarbonitrile (PCC).

  (3) Immediate precursor to fentanyl:

  (i) 4-anilino-N-phenethyl-4-piperidine (ANPP).

  (h) Anabolic steroids. Unless specifically excepted or unless listed in another schedule, "anabolic steroid" shall mean any drug or hormonal substance, chemically and pharmacologically related to testosterone (other than estrogens, progestins, corticosteroids and dehydroepiandrosterone) and includes:

  (1) 3{beta}, 17-dihydroxy-5a-androstane.

  (2) 3{alpha}, 17{beta}-dihydroxy-5a-androstane.

  (3) 5{alpha}-androstan-3,17-dione.

  (4) 1-androstenediol (3{beta},17{beta}-dihydroxy-5{alpha}-androst-1- ene).

  (5) 1-androstenediol (3{alpha},17{beta}-dihydroxy-5{alpha}-androst-1- ene).

  (6) 4-androstenediol (3{beta}, 17{beta}-dihydroxy-androst-4-ene).

  (7) 5-androstenediol (3{beta}, 17{beta}-dihydroxy-androst-5-ene).

  (8) 1-androstenedione ({5{alpha}}-androst-1-en-3,17-dione).

  (9) 4-androstenedione (androst-4-en-3,17-dione).

  (10) 5-androstenedione (androst-5-en-3,17-dione).

  (11) Bolasterone (7{alpha},17{alpha}-dimethyl-17{beta}-hydroxyandrost- 4-en-3-one).

  (12) Boldenone (17{beta}-hydroxyandrost-1, 4,-diene-3-one).

  (13) Boldione (androsta-1,4-diene-3,17-dione).

  (14) Calusterone (7{beta}, 17{alpha}-dimethyl-17{beta}-hydroxyandrost- 4-en-3-one).

  (15) Clostebol (4-chloro-17{beta}-hydroxyandrost-4-en-3-one).

  (16) Dehydrochloromethyltestosterone (4-chloro-17{beta}-hydroxy-17 {alpha}-methyl-androst-1, 4-dien-3-one).

  (17) {Delta} 1-dihydrotestosterone (a.k.a. '1-testosterone') (17 {beta}-hydroxy-5{alpha}-androst-1-en-3-one).

  (18) 4-dihydrotestosterone (17{beta}-hydroxy-androstan-3-one).

  (19) Drostanolone (17{beta}-hydroxy-2{alpha}-methyl-5{alpha} -androstan-3-one).

  (20) Ethylestrenol (17{alpha}-ethyl-17{beta}-hydroxyestr- 4-ene).

  (21) Fluoxymesterone (9-fluoro-17{alpha}-methyl-11{beta}, 17 {beta}- dihydroxyandrost-4-en-3-one).

  (22) Formebolone (2-formyl-17{alpha}-methyl-11{alpha}, 17{beta}-dihydroxyandrost-1, 4-dien-3-one).

  (23) Furazabol (17{alpha}-methyl-17{beta}-hydroxyandrostano {2, 3-c}-furazan).

  (24) 13{beta}-ethyl-17{beta}-hyroxygon-4-en-3-one.

  (25) 4-hydroxytestosterone (4, 17{beta}-dihydroxy-androst-4-en-3-one).

  (26) 4-hydroxy-19-nortestosterone (4,17{beta}-dihydroxy-estr-4-en-3-one).

  (27) desoxymethyltestosterone (17{alpha}-methyl-5{alpha}-androst-2-en-17{beta}-ol) (a.k.a., madol).

  (28) Mestanolone (17{alpha}-methyl-17{beta}-hydroxy- 5-androstan-3-one).

  (29) Mesterolone (1{alpha} methyl-17{beta}-hydroxy- {5{alpha}}-androstan-3-one).

  (30) Methandienone (17{alpha}-methyl-17{beta}-hydroxyandrost-1, 4-dien-3-one).

  (31) Methandriol (17{alpha}-methyl-3{beta}, 17{beta}-dihydroxyandrost-5-ene).

  (32) Methenolone (1-methyl-17{beta}-hydroxy-5{alpha}-androst- 1-en-3-one).

  (33) 17{alpha}-methyl-3{beta},17{beta}-dihydroxy-5a-androstane.

  (34) 17{alpha}-methyl-3{alpha}, 17{beta}-dihydroxy- 5a-androstane.

  (35) 17{alpha}-methyl-3{beta}, 17{beta}-dihydroxyandrost-4-ene.

  (36) 17{alpha}-methyl-4-hydroxynandrolone (17{alpha}-methyl-4- hydroxy-17{beta}-hydroxyestr-4-en-3-one).

  (37) Methyldienolone (17{alpha}-methyl-17{beta}-hydroxyestra- 4,9(10)-dien-3-one).

  (38) Methyltrienolone (17{alpha}-methyl-17{beta}-hydroxyestra-4, 9-11-trien-3-one).

  (39) Methyltestosterone (17{alpha}-methyl-17{beta}-hydroxyandrost- 4-en-3-one).

  (40) Mibolerone (7{alpha},17{alpha}-dimethyl-17{beta}-hydroxyestr- 4-en-3-one).

  (41) 17{alpha}-methyl-{Delta} 1-dihydrotestosterone (17b{beta}-hydroxy-17{alpha}-methyl-5{alpha}-androst-1-en-3-one) (a.k.a. '17-{alpha}-methyl-1-testosterone').

  (42) Nandrolone(17{beta}-hydroxyestr-4-en-3-one).

  (43) 19-nor-4-androstenediol (3{beta},17{beta}-dihydroxyestr -4-ene).

  (44) 19-nor-4-androstenediol (3{alpha},17{beta}-dihydroxyestr-4-ene).

  (45) 19-nor-5-androstenediol (3{beta},17{beta}-dihydroxyestr -5-ene).

  (46) 19-nor-5-androstenediol (3{alpha},17{beta}-dihydroxyestr-5-ene).

  (47) 19-nor-4,9(10)-androstadienedione (estra-4,9(10)-diene-3,17-dione).

  (48) 19-nor-4-androstenedione (estr-4-en-3,17-dione).

  (49) 19-nor-5-androstenedione (estr-5-en-3,17-dione).

  (50) Norbolethone (13{beta}, 17{alpha}-diethyl-17{beta} -hydroxygon-4-en-3-one).

  (51) Norclostebol (4-chloro-17{beta}-hydroxyestr-4-en-3-one).

  (52) Norethandrolone (17{alpha}-ethyl-17{beta}-hydroxyestr- 4-en-3-one).

  (53) Normethandrolone (17{alpha}-methyl-17{beta} -hydroxyestr-4-en-3-one).

  (54) Oxandrolone (17{alpha}-methyl-17{beta}-hydroxy-2-oxa- {5{alpha}}-androstan-3-one).

  (55) Oxymesterone (17{alpha}-methyl-4, 17{beta}-dihydroxy androst-4-en-3-one).

  (56) Oxymetholone (17 {alpha}-methyl-2-hydroxymethylene-17 {beta}-hydroxy-{5{alpha}}- androstan-3-one).

  (57) Stanozolol (17{alpha}-methyl-17{beta}-hydroxy-{5{alpha}}- androst-2-eno{3, 2-c}-pyrazole).

  (58) Stenbolone (17{beta}-hydroxy-2-methyl-{5{alpha}}-androst- 1-en-3-one).

  (59) Testolactone (13-hydroxy-3-oxo-13, 17-secoandrosta-1, 4-dien-17-oic acid lactone).

  (60) Testosterone (17{beta}-hydroxyandrost-4-en-3-one).

  (61) Tetrahydrogestrinone (13{beta}, 17{alpha}-diethyl -17{beta}-hydroxygon-4, 9, 11-trien-3-one).

  (62) Trenbolone (17{beta}-hydroxyestr-4, 9, 11-trien-3-one).

  (63) Any salt, ester or ether of a drug or substance described or listed in this subdivision.

  (i) Subdivision (h) of this section shall not include any substance containing anabolic steroids expressly intended for administration through implants to cattle or other nonhuman species and that are approved by the federal food and drug administration solely for such use. Any individual who knowingly and willfully administers to himself or another person, prescribes, dispenses or distributes such substances for other than implantation to cattle or nonhuman species shall be subject to the same penalties as a practitioner who violates the provisions of this section or any other penalties prescribed by law.

  Schedule III. (a) Schedule III shall consist of the drugs and other substances, by whatever official name, common or usual name, chemical name, or brand name designated, listed in this section.

  (b) Stimulants. Unless specifically excepted or unless listed in another schedule, any material, compound, mixture, or preparation which contains any quantity of the following substances having a stimulant effect on the central nervous system, including its salts, isomers (whether optical, position, or geometric), and salts of such isomers whenever the existence of such salts, isomers, and salts of isomers is possible within the specific chemical designation:

  (1) Those compounds, mixtures, or preparations in dosage unit form containing any stimulant substances listed in schedule II which compounds, mixtures, or preparations were listed on August twenty-five, nineteen hundred seventy-one, as excepted compounds under title twenty-one, section 308.32 of the code of federal regulations and any other drug of the quantitive composition shown in that list for those drugs or which is the same except that it contains a lesser quantity of controlled substances.

  (2) Benzphetamine.

  (3) Chlorphentermine.

  (4) Clortermine.

  (6) Phendimetrazine.

  (c) Depressants. Unless specifically excepted or unless listed in another schedule, any material, compound, mixture, or preparation which contains any quantity of the following substances having a depressant effect on the central nervous system, including its salts, isomers, and salts of isomers:

  (1) Any compound, mixture or preparation containing:

  (i) Amobarbital;

  (ii) Secobarbital;

  (iii) Pentobarbital; or any salt thereof and one or more other active medicinal ingredients which are not listed in any schedule.

  (2) Any suppository dosage form containing:

  (i) Amobarbital;

  (ii) Secobarbital;

  (iii) Pentobarbital; or any salt of any of these drugs and approved by the federal food and drug administration for marketing only as a suppository.

  (3) Any substance which contains any quantity of a derivative of barbituric acid or any salt thereof.

  (4) Chlorhexadol.

  (5) Lysergic acid.

  (6) Lysergic acid amide.

  (7) Methyprylon.

  (8) Sulfondiethylmethane.

  (9) Sulfonethylmethane.

  (10) Sulfonmethane.

  (11) Tiletamine and zolazepam or any salt thereof. Some trade or other names for a tiletamine-zolazepam combination product: Telazol. Some trade or other names for tiletamine: 2-(ethylamino) -2-(2-thienyl) -cyclohexanone. Some trade or other names for zolazepam: 4-(2-fluorophenyl) -6,8-dihydro -1, 3, 8i-trimethylpyrazolo-{3,4-e} {1,4} -diazepin-7(1H)-one, flupyrazapon.

  (12) Gamma hydroxybutyric acid, and salt, hydroxybutyric compound, derivative or preparation of gamma hydroxybutyric acid, including any isomers, esters and ethers and salts of isomers, esters and ethers of gamma hydroxybutyric acid, contained in a drug product for which an application has been approved under section 505 of the federal food, drug and cosmetic act.

  (13) Ketamine, its salts, isomers and salts of isomers (some other names for ketamine: (±)-2-(2-chlorophenyl)-2-(methylamino)- cyclohexanone).

  (14) Embutramide.

  (d) Nalorphine.

  (e) Narcotic drugs. Unless specifically excepted or unless listed in another schedule, any material, compound, mixture, or preparation containing any of the following narcotic drugs, or their salts calculated as the free anhydrous base or alkaloid, in limited quantities as set forth below:

  (1) Not more than 1.8 grams of codeine per one hundred milliliters or not more than ninety milligrams per dosage unit, with an equal or greater quantity of an isoquinoline alkaloid of opium.

  (2) Not more than 1.8 grams of codeine per one hundred milliliters or not more than ninety milligrams per dosage unit, with one or more active, nonnarcotic ingredients in recognized therapeutic amounts.

  (3) Not more than 1.8 grams of dihydrocodeine per one hundred milliliters or not more than ninety milligrams per dosage unit, with one or more active nonnarcotic ingredients in recognized therapeutic amounts.

  (4) Not more than three hundred milligrams of ethylmorphine per one hundred milliliters or not more than fifteen milligrams per dosage unit, with one or more active, nonnarcotic ingredients in recognized therapeutic amounts.

  (5) Not more than five hundred milligrams of opium per one hundred milliliters or per one hundred grams or not more than twenty-five milligrams per dosage unit, with one or more active, nonnarcotic ingredients in recognized therapeutic amounts.

  (6) Not more than fifty milligrams of morphine per one hundred milliliters or per one hundred grams, with one or more active, nonnarcotic ingredients in recognized therapeutic amounts.

  (7) Buprenorphine in any quantities.

  (f) Dronabinol (synthetic) in sesame oil and encapsulated in a soft gelatin capsule in a U.S. Food and Drug Administration approved product.

  Some other names for dronabinol include: (6aR-trans)-6a, 7, 8, 10a-tetrahydro-6, 6, 9-trimethyl-3-pentyl-6H-dibenzo{b,d} pyran-1-o1, or (-)-delta-9-(trans) - tetrahydrocannabinol.

  (g) Chorionic gonadotropin. Unless specifically excepted or unless listed in another schedule any material, compound, mixture, or preparation which contains any amount of chorionic gonadotropin.

  Schedule IV. (a) Schedule IV shall consist of the drugs and other substances, by whatever official name, common or usual name, chemical name, or brand name designated, listed in this section.

  (b) Narcotic drugs. Unless specifically excepted or unless listed in another schedule, any material, compound, mixture, or preparation containing any of the following narcotic drugs, or their salts calculated as the free anhydrous base or alkaloid, in limited quantities as set forth below:

  (1) Not more than one milligram of difenoxin and not less than twenty-five micrograms of atropine sulfate per dosage unit.

  (2) Dextropropoxyphene (alpha-(+)-4-dimethylamino-1, 2-diphenyl-3- methyl-2-propionoxybutane).

  (c) Depressants. Unless specifically excepted or unless listed in another schedule, any material, compound, mixture, or preparation which contains any quantity of the following substances, including its salts, isomers, and salts of isomers whenever the existence of such salts, isomers, and salts of isomers is possible within the specific chemical designation:

  (1) Alprazolam.

  (2) Barbital.

  (3) Bromazepam.

  (4) Camazepam.

  (5) Chloral betaine.

  (6) Chloral hydrate.

  (7) Chlordiazepoxide.

  (8) Clobazam.

  (9) Clonazepam.

  (10) Clorazepate.

  (11) Clotiazepam.

  (12) Cloxazolam.

  (13) Delorazepam.

  (14) Diazepam.

  (15) Estazolam.

  (16) Ethchlorvynol.

  (17) Ethinamate.

  (18) Ethyl Loflazepate.

  (19) Fludiazepam.

  (20) Flunitrazepam.

  (21) Flurazepam.

  (22) Halazepam.

  (23) Haloxazolam.

  (24) Ketazolam.

  (25) Loprazolam.

  (26) Lorazepam.

  (27) Lormetazepam.

  (28) Mebutamate.

  (29) Medazepam.

  (30) Meprobamate.

  (31) Methohexital.

  (32) Methylphenobarbital (mephobarbital).

  (33) Nimetazepam.

  (34) Nitrazepam.

  (35) Nordiazepam.

  (36) Oxazepam.

  (37) Oxazolam.

  (38) Paraldehyde.

  (39) Petrichoral.

  (40) Phenobarbital.

  (41) Pinazepam.

  (42) Prazepam.

  (43) Temazepam.

  (44) Tetrazepam.

  (45) Triazolam.

  (46) Midazolam.

  (47) Quazepam.

  (48) Zolpidem.

  (49) Dichloralphenazone.

  (50) Zaleplon.

  (51) Zopiclone (eszopiclone).

  (52) Fospropofol.

  (53) Carisoprodol.

  * (d) Fenfluramine. Any material, compound, mixture, or preparation which contains any quantity of the following substances, including its salts, isomers (whether optical, position, or geometric), and salts of such isomers, whenever the existence of such salts, isomers and salts of isomers is possible:

  (1) Fenfluramine.

  * NB Repealed upon the removal of fenfluramine and its salts and isomers from Schedule IV of the federal Controlled Substances Act

  (e) Stimulants. Unless specifically excepted or unless listed in another schedule, any material, compound, mixture, or preparation which contains any quantity of the following substances having a stimulant effect on the central nervous system, including its salts, isomers, and salts of such isomers:

  (1) Cathine ((+) - norpseudoephedrine).

  (2) Diethylpropion.

  (3) Fencamfamin.

  (4) Fenproporex.

  (5) Mazindol.

  (6) Mefenorex.

  (7) Pemoline (including organometallic complexes and chelates thereof).

  (8) Phentermine.

  (9) Pipradrol.

  (10) SPA((-))-1-dimethylamino-1, 2-diphenylethane).

  (11) Modafinil.

  (12) Sibutramine.

  (f) Other substances. Unless specifically excepted or unless listed in another schedule, any material, compound, mixture or preparation which contains any quantity of the following substances, including its salts:

  (1) Pentazocine.

  (2) Butorphanol (including its optical isomers).

  (3) Tramadol in any quantities.

  Schedule V. (a) Schedule V shall consist of the drugs and other substances, by whatever official name, common or usual name, chemical name, or brand name designated, listed in this section.

  (b) Narcotic drugs containing nonnarcotic active medicinal ingredients. Any compound, mixture, or preparation containing any of the following narcotic drugs, or their salts calculated as the free anhydrous base or alkaloid, in limited quantities as set forth below, which shall include one or more nonnarcotic active medicinal ingredients in sufficient proportion to confer upon the compound, mixture, or preparation valuable medicinal qualities other than those possessed by narcotic drugs alone:

  (1) Not more than two hundred milligrams of codeine per one hundred milliliters or per one hundred grams.

  (2) Not more than one hundred milligrams of dihydrocodeine per one hundred milliliters or per one hundred grams.

  (3) Not more than one hundred milligrams of ethylmorphine per one hundred milliliters or per one hundred grams.

  (4) Not more than 2.5 milligrams of diphenoxylate and not less than twenty-five micrograms of atropine sulfate per dosage unit.

  (5) Not more than one hundred milligrams of opium per one hundred milliliters or per one hundred grams.

  (6) Not more than 0.5 milligram of difenoxin and not less than twenty-five micrograms of atropine sulfate per dosage unit.

  (c) Stimulants. Unless specifically exempted or excluded or unless listed in another schedule, any material, compound, mixture, or preparation which contains any quantity of the following substances having a stimulant effect on the central nervous system, including its salts, isomers and salts of isomers:

  (1) Pyrovalerone.

  (d) Depressants. Unless specifically exempted or excluded or unless listed in another schedule, any material, compound, mixture, or preparation which contains any quantity of the following substances having a depressant effect on the central nervous system, including its salts, isomers, and salts of isomers:

  (1) Ezogabine {N-{2-amino-4-(4-fluorobenzylamino)-phenyl}-carbamic acid ethyl ester}.

  (2) Lacosamide {(R)-2-acetoamido-N-benzyl-3-methoxy-propionamide}.

  (3) Pregabalin {(S)-3-(aminomethyl)-5-methylhexanoic acid }.